Recently, we demonstrated that SIRT7 directly interacts with ARF in lung cancer cells and promotes its proteasomal-dependent degradation by inhibiting its interaction with NPM1.7 This event prevents ARF from repressing genes involved in stimulation of cancer cells growth, thereby facilitating lung cancer progression (Figure 1).7 Here, SIRT7 is linked to lung cancer.